Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · page 20 of 44
The slide outlines a complex clinical trial structure involving rollovers from Study 0169 and de novo participants, leading into a randomized withdrawal period.
Conference presentation · appendix_methodology · present_framework · dense density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 disclaimer 1/1 list 2/2 title 1/1
Components 5
timeline disclaimer bullet bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1